https://mindmedicinelaw.com/briefing/psychedelic-healing-initiative-for-system-impacted-individuals-20260618-14320The Psychedelic Journalen2026-06-18T22:04:06.073895+00:00Psychedelic Healing Initiative for System-Impacted Individualspsychedelic-assisted healing, system-impacted individuals, marginalized communities, policy reform, public health, clinical trials, psilocybin, MDMA, equity in research, therapeutic potentialhttps://mindmedicinelaw.com/briefing/durable-change-framework-in-psychiatry-implications-for-trials-20260617-14083The Psychedelic Journalen2026-06-18T15:04:51.772159+00:00Durable Change Framework in Psychiatry: Implications for Trialspsychiatric treatment, high-plasticity brain states, clinical trial design, psychedelic-assisted therapy, brain plasticity, durable psychological change, critical periods, transcranial magnetic stimulation, deep brain stimulation, treatment efficacyhttps://mindmedicinelaw.com/briefing/community-driven-psilocybin-therapy-study-in-new-mexico-20260617-14046The Psychedelic Journalen2026-06-18T15:04:39.160785+00:00Community-Driven Psilocybin Therapy Study in New Mexicopsilocybin therapy, community engagement, PTSD treatment, New Mexico, equitable access, economic analysis, clinical trials, psychedelic research, mental health, policy implicationshttps://mindmedicinelaw.com/briefing/psilocybin-s-long-term-antidepressant-effects-clinical-insights-20260617-13999The Psychedelic Journalen2026-06-17T22:04:00.156832+00:00Psilocybin's Long-Term Antidepressant Effects: Clinical Insightspsilocybin, antidepressant effects, psychotherapy, depression treatment, psychedelic therapy, clinical guidelines, mental health, FDA, serotonin receptors, psychedelic researchhttps://mindmedicinelaw.com/briefing/youth-addiction-interventions-insights-and-challenges-20260616-14066The Psychedelic Journalen2026-06-18T15:05:01.743051+00:00Youth Addiction Interventions: Insights and Challengesyouth addiction interventions, substance addiction, behavioral addiction, children and adolescents, psychotherapy, educational interventions, public health, addiction research, early intervention, stakeholder collaborationhttps://mindmedicinelaw.com/briefing/oregon-court-case-examines-psilocybin-home-access-laws-20260616-13522The Psychedelic Journalen2026-06-17T22:04:09.198285+00:00Oregon Court Case Examines Psilocybin Home Access Lawspsilocybin, Oregon law, home access, psychedelic regulation, Measure 109, legal precedent, community practices, state policy, court case, public safetyhttps://mindmedicinelaw.com/briefing/etomidate-vs-ketamine-emergency-intubation-review-20260616-13514The Psychedelic Journalen2026-06-17T15:06:01.223798+00:00Etomidate vs Ketamine: Emergency Intubation Reviewketamine, etomidate, emergency intubation, critical care, meta-analysis, clinical trials, psychedelic research, mental health, anesthesia, public healthhttps://mindmedicinelaw.com/briefing/mescaline-s-clinical-potential-a-primer-for-clinicians-20260616-13763The Psychedelic Journalen2026-06-17T15:05:45.448097+00:00Mescaline's Clinical Potential: A Primer for Cliniciansmescaline, psychedelic therapy, clinical trials, serotonin-2A receptor, psychiatric benefits, safety profile, controlled studies, therapeutic potential, psychiatric comorbidities, psychoactive effectshttps://mindmedicinelaw.com/briefing/tiny-dose-psilocybin-pills-implications-for-clinical-trials-20260616-13840The Psychedelic Journalen2026-06-17T15:05:35.158076+00:00Tiny-Dose Psilocybin Pills: Implications for Clinical Trialspsilocybin, microdosing, clinical trials, psychedelic research, regulatory approvals, mental healthhttps://mindmedicinelaw.com/briefing/ketamine-s-impact-on-sleep-in-treatment-resistant-depression-20260616-13773The Psychedelic Journalen2026-06-17T15:05:10.610664+00:00Ketamine's Impact on Sleep in Treatment-Resistant Depressionketamine, treatment-resistant depression, slow-wave activity, sleep architecture, antidepressant effects, clinical trials, neuroscience, NREM sleep, psychiatric treatment, sleep modulationhttps://mindmedicinelaw.com/briefing/psilocybin-vs-escitalopram-brain-dynamics-in-depression-20260616-13764The Psychedelic Journalen2026-06-17T15:04:57.502158+00:00Psilocybin vs. Escitalopram: Brain Dynamics in Depressionpsilocybin, escitalopram, major depressive disorder, brain dynamics, fluctuation-dissipation theorem, biomarkers, clinical trials, fMRIhttps://mindmedicinelaw.com/briefing/kmt-as-adjunct-to-cbt-for-bipolar-disorder-potential-and-challenges-20260615-13774The Psychedelic Journalen2026-06-17T22:04:34.123976+00:00KMT as Adjunct to CBT for Bipolar Disorder: Potential and Challengesketogenic metabolic therapy, cognitive behavioral therapy, bipolar disorder, mental health treatment, therapy participation, mood stability, clinical trials, psychotherapy, treatment adherencehttps://mindmedicinelaw.com/briefing/comt-gene-polymorphism-and-ocd-risk-in-bangladesh-20260615-13730The Psychedelic Journalen2026-06-17T22:04:25.662070+00:00COMT Gene Polymorphism and OCD Risk in BangladeshCOMT gene, OCD risk, Bangladesh, genetic polymorphism, Val158Met, dopamine metabolism, psychiatric disorders, case-control study, genotyping, personalized treatmenthttps://mindmedicinelaw.com/briefing/orexins-influence-epileptiform-activity-in-rat-hippocampus-20260615-13775The Psychedelic Journalen2026-06-17T22:04:17.086967+00:00Orexins Influence Epileptiform Activity in Rat Hippocampusorexins, epileptiform activity, hippocampus, orexin-A, OX1 receptor, epilepsy treatment, neuroscience, clinical trials, rat models, neuropeptideshttps://mindmedicinelaw.com/briefing/psilocybin-therapy-in-mdd-efficacy-and-research-needs-20260615-13727The Psychedelic Journalen2026-06-17T15:05:23.077541+00:00Psilocybin Therapy in MDD: Efficacy and Research Needspsilocybin therapy, major depressive disorder, systematic review, meta-analysis, clinical trials, psychedelic research, mental health treatment, evidence certainty, risk of bias, long-term efficacyhttps://mindmedicinelaw.com/briefing/scoping-review-on-modern-mental-health-challenges-20260613-13731The Psychedelic Journalen2026-06-17T22:04:40.547101+00:00Scoping Review on Modern Mental Health Challengesmental health challenges, integrated interventions, culturally responsive, digital mental health, climate anxiety, equity in mental health